You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer

 

Online download statistics by month:

Online download statistics by month: February 2021 to July 2025

AbstractFullPdf
Feb 2021428428307
Mar 2021251249109
Apr 202112812664
May 202114114134
Jun 202114914937
Jul 202110910934
Aug 202113213253
Sep 2021848440
Oct 202111011046
Nov 202111411450
Dec 2021888821
Jan 2022919444
Feb 2022747657
Mar 2022136143110
Apr 2022868767
May 2022868760
Jun 2022838735
Jul 2022869047
Aug 2022767648
Sep 20229610073
Oct 2022929650
Nov 2022606026
Dec 2022585832
Jan 2023485038
Feb 2023868643
Mar 2023899031
Apr 2023525233
May 2023464728
Jun 2023717131
Jul 2023585832
Aug 2023464615
Sep 2023596020
Oct 2023595927
Nov 2023797922
Dec 202319319331
Jan 2024444621
Feb 2024343424
Mar 2024474781
Apr 2024444325
May 2024414124
Jun 2024575739
Jul 2024576024
Aug 2024414058
Sep 20245051207
Oct 2024585886
Nov 2024404118
Dec 2024555626
Jan 2025373720
Feb 2025292921
Mar 2025545438
Apr 2025989953
May 2025262620
Jun 2025363629
Jul 2025110
Total449345312609